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HEPATIC ARTERY THROMBOSIS AFTER PEDIATRIC LIVER 
TRANSPLANTATION-A MEDICAL OR SURGICAL EVENT?1 
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Hepatic artery thrombosis (HAT) is one of the most 
serious complications after orthotopic liver transplan-
tation, and is associated with a high morbidity and mor-
tality. This study retrospectively reviewed 66 liver 
transplants in children under the age of 10 years during 
a year-long period at a single institution. A total of 28 
perioperative variables were analyzed to identify re-
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sponsible factors of HAT. Of the 66 children, 18 (26%) 
developed HAT within 15 days after the transplant 
(HAT group); 29 (42%) had an uneventful postoperative 
course (control group). To avoid the possible influence 
of other complications 19 patients were excluded. Of the 
variables compared between the 2 study groups, three 
surgical factors (diameter of the hepatic artery-
greater or less than 3 mm; type of arterial anastomo-
sis-end-to-end versus the use of an iliac graft or aortic 
conduit; and number of times the anastomosis was re-
done-one versus more than one), were found to be 
significantly different (P<.05) between HAT and con-
trol groups. Two medical factors also were significantly 
different: the use of intraoperative transfusion of fresh 
frozen plasma (FFP) and the administration of postop-
erative prophylactic anticoagulant treatment. A heparin 
and dextran-40 protocol appeared to be effective in 
preventing BAT (P<.02). Moreover, after multivariate 
analysis, anticoagulation therapy was demonstrated to 
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be the major i~dependent variable inlluencing HAT. A 
better definition of factors responsible for the occur-
rence of HAT is required. This study should help in 
formulating effective methods to decrease the incidence 
of this dreaded complication after liver transplantation. 
Thrombosis of the hepatic artery (HA T)* is common, and is 
one of the most serious complications following orthotopic liver 
transplantation (OLTx). Several reports on this subject (1-3) 
have failed to identify possible risk factors that may be related 
to thrombosis of the hepatic artery. Nonetheless a clear defi-
nition of the responsible factors is necessary in order to reduce 
its incidence and to formulate guidelines and protocols for the 
management of this dreaded complication. 
In the present study two homogeneous and comparable pop-
ulations-pediatric liver recipients who developed thrombosis 
of the hepatic artery after OLTx and those who did not-have 
been identified. An accurate statistical comparison between 
these two groups has been carried out in an attempt to identify 
the responsible factors leading to thrombosis. 
MATERIALS AND METHODS 
Patient population (Table 1). During the calendar year 1986, 66 
consecutive children under the age of 10 years received primary liver 
transplant at the Children's Hospital of Pittsburgh. 
The methods of patient selection, techniques for orthotopic liver 
transplantation, protocols for immunosuppressive management and 
postoperative care have been described in detail previously E4~FK 
A total of 18 children with hepatic artery thrombosis that occurred 
within 15 days of transplantation were included in the HAT group 
(26% of the whole series). The diagnosis of HAT was usually suspected 
in the presence of fulminant hepatic necrosis, biliary leak, or recurrent 
bacteremia, and was always confirmed by sonography and/or angiog-
raphy. 
A group of 19 children with a major posttransplant complication 
(i.e., primary nonfunction of the graft, sepsis, reoperation for bleeding, 
bowel perforation, and biliary leak) were excluded from the study, and 
only 29 patients (42%) with a relatively uneventful postoperative course 
during the first month were taken as a control group. At least one 
sonogram was performed routinely in all the patients in this study-
controls, 1:IAT, and excluded ones-to conflI'lll hepatic artery patency. 
If a pu!sii'tile artery was not clearly seen, an angiographic study was 
performed in each patient regardless of group status. Posttransplant 
ma"nagement of all recipients was also comparable in all the patients. 
The arterial reconstructions were performed with an end-to-end 
anastomosis (EEA) between donor and recipient arteries in 40 in-
stances (13 of 18 patients in the HAT group and 17 out of 29 controls). 
In seven patients either a donor iliac artery allograft or an aortic 
conduit was eventually placed on the infrarenal aorta and then brought 
up to the liver hilum through a retropancreatic tunnel (7) (Table 2). 
The anastomoses were performed mainly at the level of the celiac axis 
or common hepatic artery of the recipient (61.1% and 62.1 % of cases 
in the two groups, respectively). A complete list of the levels of anas-
tomosis is summarized in Table 2. In two control patients the splenic 
artery was ligated close to the celiac axis after an EEA of the hepatic 
artery in an attempt to prevent a possible "steal" from the small-
diameter hepatic artery anastomosis. 
A running continuous suture with a "growth factor" was used for 
most of the arterial anastomoses (8); interrupted suture was used for 
the anterior wall of the anastomosis in 5 of 29 controls and in 2 of 18 
patients who suffered thrombosis of the hepatic artery, and 7-0 mono-
• Abbreviations: EEA, ~nd-to·end anastomosis; HAT, hepatic artery 
thrombosis; FFP, fresh frozen plasma; OLTx, orthotopic liver trans-
plantation. 
f1lament (Prolene-Ethicon or Novafil-Davis-Geck) was used to 
all the anastomoses. 
A total of 28 perioperative variables from both the donor 
recipient for each transplant were recorded and are listed in 
2, and 3. In particular, information about the preoperative 
status of all patients was collected for the analysis. Int:raClpelratil...i7i. 
the worst coagulation status (i.e., the lowest PT and PTT, ibid 
highest hematocrit and platelet count) was also evaluated Blood ... 
and the quantity and type of transfusions have been analyzed _ ... 
(9-11). The blood volumes required to replace the blood loa. ... 
estimated as 70 ml/kg in children older than 2 ye81'l and 80 1IIJIq .. : 
patients 0-2 years of age. k 
The anticoagulation therapy was administered in a random ~ 
because of the preliminary nature of this therapeutic investiratioa, 
Dosages of the medications used were as follows:,;.,>:c( 
Dextran-40: 5-10 ml/hr starting intraoperatively immediately ... · 
the transplant and continued for 5 days. 
Heparin: 50 U/kg divided into 2 daily doses subcutaneoualy. atattiiI· 
postoperatively as soon as the PT and PTT were less than 20 .,,4,/; 
40 sec, respectively. Heparin was discontinued at the time of .... 
charge. .',il 
Aspirin (ASA): 20 mg orally or as a suppository for children ~
<10 kg; 40 mg for children >10 kg. Therapy was continued for at 
least 3 months. 
Persantine (dypiridamole): 12.5 mg p.o. 3 times a day for children 
weighing <20 kg; 25 mg p.o. 3 times a day for children >20 kg startinc 
from the 5th or 6th postoperative day and continued for at least 3 
months. 
Statistical analysis. The variables listed in Tables 1, 2, and 3 were 
investigated to determine any statistically significant difference 
(P<.05) between "cases" (HAT-group) and "controls" (uneventful 
postoperative course). 
When this many comparisons are undertaken, the multiple compar-
ison problem comes into play; in fact with 28 variables examined, there 
is about 76% probability of finding at least one variable that will be 
statistically significant and associated with group status (cases or 
controls) by chance alone; thus statistical tests of significance were 
employed in an exploratory manner. 
To identify continuous variables both parametric and nonparametrie 
tests were used. The Student's t test and chi-square were employed; in 
addition the nonparametric Wilcoxon and median tests were used for 
differences in central tendency. 
The logistic regression model finally provided an estimation of the 
risk of having a hepatic artery thrombosis (odds ratio) in groups defined 
by the kind of prophylactic anticoagulative treatment used postopera-
tively. 
The entire statistical analysis was performed on an IBM·PC com-
puter utilizing the BMDP statistical software package (12, 13). 
RESULTS 
During the year 1986, 66 children under 10 years of age 
received primary liver transplants at the Children's Hospital 
of Pittsburgh. Thrombosis of the hepatic artery occurred within 
15 days after the transplant (5.3±1.2 days) in 18 patients (26% 
ofthe cases) and they formed the HAT group. Of the remaining 
48 patients, 19 developed other major complications and thus 
were excluded. The control group consisted of 29 children (42% 
of the cases) with a relatively uneventful postoperative course. 
Demographics for the 47 patients studied are presented in 
Table 1. No statistical difference was found in terms of age, 
sex, body weight, blood type predominance, and indication for 
OLTx (biliary atresia in more than 75% of the cases) between 
the HAT group and controls. 
The surgically related factors that were analyzed are listed 
in Table 2. Of 18 patients who developed thrombosis, 10 had a 
hepatic artery diameter of :s3 mm, whereas only 7 of 29 controls 
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TABLE 1. General characteristics of pediatric liver transplant patients (under 10 years of age) listed by group status 
Variable Hepatic Artery Controls P (No.) Thrombosis value 
Cases: 18 29 
(1) Age (years): 
Mean ± SE 2.9±O.65 2.6±0.3 
Median 2.0 2.3 NS 
Minimum-maximum 0.1-9.7 0.5-7.7 
(2) Sex (male/female): 7/11 13/16 NS 
(38.9%)/(61.1%) (44.8%)/(55.2%) 
(3) Body weight (kg) (mean ± SE): 1l.4±1.46 12.7±1.04 NS 
(4) Blood type 
0 11 (61.1%) 12 (41.4%) NS 
A 5 (27.8%) 10 (34.5%) 
B 2 (11.1%) 6 (20.7%) 
AB 0(0%) 1 (3.4%) 
(5) Diagnosis: 
Biliary atresia 14 (77.8%) 23 (79.7%) NS 
Other (metabolic errors, congenital hepatic fibrosis, 4 (22.2%) 6 (17.2%) 
hepatitis, etc.) 
TABLE 2. Surgical factors analyzed for possible relationship with the occurrence of thrombosis of the hepatic artery 
(No.) Variable Hepatic artery Controls Pvalue -thrombosis .' 
(6) Size of the hepatic artery (diameter): <.05 
:s3mm. 10 (55.6%) 7(24.1%) 
>3mm. 8 (44.4%) 22 (75.9%) 
(7) Level of the anastomosis: NS 
Celiac axis 6 (33.3%) 10 (34.5%) 
Common hepatic artery 5 (27.8%) 8 (27.6%) 
Gastroduodenal takeoff 1 (5.6%) 6 (20.7%) 
Splenic artery 1 (5.6%) 2 (6.9%) 
Aorta 5 (27.8%) 3 (10.3%) 
(8) Anomalies in arterial anatomy of the donor liver that NS 
required a backtable reconstruction: 
No 14 (77.8%) 28 (96.6%) 
Yes 4 (22.2%) 1 (3.4%) 
(9) Kind of arterial reconstruction: <.05 
End-to-end 13 (72.2%) 27 (93.1%) 
Other (iliac graft, aortic conduit, etc.) 5 (27.8%) 2 (6.8%) 
(10) No. of times the anastomosis was done intraoperatively: <.02 
One 
Two or more 
(11) Suture material: 
Prolene (Ethicon) 
Novafil (Davis-Geck) 
had a hepatic artery of this size (P<.05). The diameter of the 
artery was determined intraoperatively just prior to the actual 
anastomosis using the caliber on the knife stick. The number 
of times the anastomosis was redone to achieve a satisfactory 
intraoperative result was significantly associated with HAT. In 
fact, two or more attempts at arterial anastomoses occurred in 
6 of 18 patients in the HAT group (33%) but in only 1 of 29 
controls (3.4%) (P<O.02). The use of an arterial graft was 
associated with an increased risk of thrombosis, and 5 of 7 
(70%) children with arterial reconstructions that required the 
use of iliac artery grafts (3 cases) or aortic conduit (2 cases) 
developed HAT. On the other hand, a significative difference 
(P<.05) was found between the number of patients who under-
went an EEA in each group (13/18 patients of the HAT group 
(72.2%) versus 27/29 patients of the control group (93%). None 
of the children with aortic conduits had a previously attempted 
12 (66.7%) 28 (96.6%) 
6 (33.3%) 1 (3.4%) 
NS 
16 (88.9%) 21 (72.4%) 
2 (11.1 %) 8 (27.6%) 
hepatic artery EEA. Of 7 arterial grafts, 5 were preceded by an 
initial attempt at a direct anastomosis. 
The level of anastomosis (celiac axis or common hepatic 
artery accounting for over 61 % of cases in both groups) did not 
show any difference between HAT and controls. Neither the 
suture material (Prolene versus Novafil) nor the technique of 
continuous versus interrupted sutures had any significant im-
pact on the incidence of HAT. 
Medical-related factors collected for this analysis are pre-
sented in Table 3 (parts I and II). All donor livers but two were 
procured by the rapid-flush technique (14, 15) and were pre-
served in Euro-Collins solution. All grafts experienced a com-
parable total ischemia time (6.8 ± 2.3 hr). The number of non-
ABO compatible livers used in each group was not statistically 
different. 
The preoperative coagulation status and intraoperative co-
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TABLE 3. Medical factors 
I. Medical factors possibly associated with thrombosis of the hepatic artery 
(No.) Variable Hepatic artery Control Pvalue thrombosis 
(12) ABO compatibility of donor and NS 
recipient; 
Compatible 16 (88.9%) 27(93.1%) 
Not compatible 2 (ILl %) 2 (6.9%) 
Preoperative coagulation profile NS 
(mean ± SE): 
(13) PT (sec) 15.2±0.9 15.3±0.5 
(14) PTT (sec) 34.5±2.8 35.8±2.3 
(15) HTc (%) 34.2±Ll 37.6±7.5 
(16) Plat. (x 103) 244±34 182±19 
Intraoperative coagulation pro- NS 
file (mean ± SE): 
(17) PT (sec) 14.3±0.2 14.8±0.4 
(18) PTT (sec) 33.0±0.7 34.1±1.5 
(19) HTc (%) 42.3±1.6 41.9±O.5 
(20) Plat. (x10") 219±23 199±16 
(21) Blood loss (ml) NS 
Range 960-8600 260-13550 
Mean ± SE 2781±355 3018±615 
II. Medical factors (intraoperative transfusion and anticoagulant prophylactic treatments) 
No. 
(22) 
(23) 
(24) 
(25) 
(26) 
(27) 
(28) 
Transfusions and anticoagulants 
Type of transfusions: 
Whole blood 
FFP 
Platelets 
Perioperative anticoagulant therapy 
Influence of different anticoagula-
tion regimens: 
Aspirin 
Persantin 
Dextran-40 
Heparin 
Thrombosed 
4 (23.5%) 
16(94.1%) 
11 (64.7%) 
9 (50%) 
6 (33.3%) 
4 (22.2%) 
5 (27.8%) 
2 (11.1%) 
agulation parameters were similar in both the HAT group and 
controls. The mean blood loss (2781±355 ml in the HAT versus 
3018:£615 ml in the controls), and transfusion requirements 
(4.1±1.3 blood volumes in the HAT group versus 3.9±0.8 blood 
volumes in the control patients) were not significantly different. 
The influence of the different components of the transfusions 
(whole blood, fresh frozen plasma, platelets) was compared 
between the two groups. This evaluation considered only 
whether patients did or did not receive one of these blood 
components. The incidence of HAT was significantly higher 
(P<.05) in children who received an intraoperative transfusion 
of fresh frozen plasma compared with children who did not 
receive FFP at all (Table 3, part lI). No differences were found 
with respect to transfusion of whole blood or platelets. Epsilon-
Aminocaproic acid (Amicar) was never used intraoperatively 
and postoperatively in the present series. 
The use of postoperative anticoagulation correlated signifi-
cantly (P<.Ol) with the occurrence of HAT; it was adminis-
tered in almost 90% of the controls, while only 50% of the 
patients who eventually developed thrombosis received it. Ten 
different combinations of dextran-40, heparin, aspirin, and 
persantine were used in a random fashion considering the 
introductory purpose of this study in investigating the effect of 
postoperative anticoagulation. Dextran-40 followed by heparin 
YES NO 
P value 
Control Thrombosed Controls 
4 (13.5%) NS 13 (76.5%) 25 (86.2%) 
20 (69.0%) <.05 1 (5.9%) 9 (31.0%) 
12 (41.4) NS 6 (35.3%) 17 (58.6%) 
3 (10.9%) <.01 9 (50%) 26 (89.7%) 
17(58.6%) NS 12 (66.7%) 12 (41.4%) 
9(31.0%) NS 14 (77.8%) 20 (69%) 
20 (69.0%) <.02 13 (72.2%) 9 (31.0%) 
15 (51.7%) <.02 16 (88.9%) 14 (48.3%) 
was the most frequent protocol and was used in 12 cases (10 
controls and 2 HAT). The aspirin-dextran-persantine combi-
nation was employed in 7 cases, and the dextran-heparin-
aspirin in 5; The remaining combinations were varied. 
The use of dextran-40 and heparin significantly correlated 
with nonthrombosis status (P<.02); furthermore the P value 
for aspirin (<.058) approached statistical significance (Table 3, 
part II). Hemorrhage during the anticoagulant treatment oc-
curred in three cases in the control group and in 2 cases in the 
HAT group (no statistical differences); in 4 out of 5 cases a 
temporary 50% reduction in the dose of heparin was able to 
control the problem without further intervention. Only one 
control patient (2% of the total series) required an exploratory 
laparotomy along with discontinuation of the anticoagulation 
treatment. 
The risk (odds ratio) of developing HAT according to 
whether or not each medication was employed as a prophylactic 
treatment is presented in Figure 1. The risk of thrombosis was 
almost 8.6 times greater in patients who did not receive any 
anticoagulation therapy than in patients who received heparin. 
This odds ratio was 5.8 for dextran, 1.8 for aspirin, and 1.6 for 
persantine. 
A more detailed (univariate and multivariate) analysis of the 
five variables that were found to have a significant influence 
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on the occurrence of HAT revealed that the anticoagulation 
treatment was the only independent variable, with a coefficient 
of 11.7 belonging to heparin (Table 4). Further adjustments in 
the statistical analysis for heparin treatment demonstrated that 
the number of times the anastomosis was redone intraopera-
tively was the second independent variable influencing throm-
bosis. Dextran treatment did not appear in this second step of 
the multivariate analysis because it was employed with heparin 
most of the time. The same reasoning should be considered for 
the other two surgical variables (i.e., diameter of the artery and 
type of reconstruction), which did not exhibit significance 
independently after a further adjustment for the variable cor-
responding to the number of times the anastomosis was redone. 
In fact, all three surgical factors are strictly interrelated-and, 
most of the time, they occurred together during the operation. 
Finally, with further adjustments in the statistical review, 
aspirin with a coefficient of 5.3 was demonstrated to be the 
third most important factor related to the occurrence of throm-
bosis. The use of fresh frozen plasma did not demonstrate 
significance during this multivariate statistical study. A histo-
gram summarizing the influence of these two medical and three 
surgical factors is shown in Figure 2. 
DISCUSSION 
Hepatic artery thrombosis after liver transplantation is a 
devastating event associated with a very high rate of graft-
related sepsis and significant mortality (1). Its overall incidence 
is about 7-8%; however HAT has been reported to occur in 
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FIGURE 1. Relative risk (odds ratio) of thrombosis according to 
different anticoagulative regimens. For instance, the risk of developing 
thrombosis in a patient not treated with dextran is 5.8 times higher 
than a patient not given dextran in the prophylactic anticoagulative 
treatment. 
about 4% of adult patients (1, 3), 12% of pediatric cases (under 
18 years old) (1), and as many as 30% of children under the 
age of one year (16). 
Hepatic artery thrombosis usually occurs early in the post-
operative period. The clinical picture is varied and consists of 
a spectrum of fulminant hepatic necrosis, delayed biliary leak, 
or recurrent bacteremia (1). Late thrombosis may also occur 
several months after transplantation and is usually associated 
with single or multiple bile duct strictures or with relapsing 
bacteremia. Changes in liver function studies are minimal in 
cases of late thrombosis because of partial compensation of the 
hepatic arterial blood supply via collaterals around the liver 
(2). In the present series, late thrombosis occurred in 4 patients, 
after a mean interval of 195 days (range 96-240) after the 
transplant. These patients with late thrombosis have been 
excluded from the HAT group of this study. 
In this study three "surgical" factors-the diameter of the 
hepatic artery (::s3 mm), the type of arterial anastomosis (end-
to-end hepatic arterial versus other reconstructions such as use. 
of iliac arterial grafts or aortic conduits), and multiple revisions 
of the arterial anastomosis to achieve a satisfactory intraoper-
ative result-were found to be significantly different (P<.05) 
when comparing the HAT and the control groups. Similarly, 
two "medical" factors, consisting of intraoperative administra-
fJl10 
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FIGURE 2. Relative influence of medical and surgical factors on the 
incidence of hepatic artery thrombosis after liver transplantation in 
children. Negative surgical factors exert a stronger effect on the inci-
dence of thrombosis than medical factors (first three empty columns). 
Nevertheless, favorable medical factors clearly decrease the incidence 
of thrombosis (last two dotted columns). (No. of redone) number of 
times the anastomosis was redone (>1: more than one); (other) use of 
iliac graft, aortic conduit etc., (E-E) end-to-end anastomosis; (Size 
[mm» diameter of the artery (greater or less than 3 mm); (Treatment) 
use of prophylactic anticoagulative treatment (Yes: used, No: not used). 
(FFP) fresh frozen plasma. 
TABLE 4. Variate analysis of the surgical and medical risk factors of hepatic artery thrombosis after 0 L Tx in children 
Variables 
Size of hepatic artery «3 mm vs. >3 mm) 
How many reconstructions of the hepatic artery (one vs. more 
than one) 
Type of reconstruction (end-to-end vs. other reconstruction) 
FFP (fresh frozen plasma): intraoperative transfusion (some VS. 
none) 
Dextran -40 \ 
Persantin (Ves VB. no) Heparin 
Aspirin 
Univariate odds 
ratio (95% 
confidence interval) 
3.93 (1.11, 13.8) 
14.0 (1.52, 129.2) 
5.19 (0.89, 3004) 
7.20 (0.82, 62.9) 
5.78 (1.58, 21.14) 
1.57 (0040,6.45) 
8.57 (1.66, 44.2) 
2.83 (0.83, 9.67) 
Multivariate odds ratio 
(95% confidence 
interval) 
11.02 (1.0, 121.6) 
11.7 (1.6,82.5) 
5.3 (1.06, 26.8) 
------------
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tion of FFP, and postoperative anticoagulant treatment with 
either heparin or dextran-40, were also found to be statistically 
different. 
The resistance to the blood flow of any vessel is inversely 
proportional to its crossectional area; therefore the diameter of 
the hepatic artery is an obvious factor influencing the patency 
rate of the anastomosis. In fact, more than half the cases 
involving a hepatic artery with a diameter of less than 3 mm 
developed thrombosis, while 76% of the arteries with a diameter 
greater than 3 mm did not thrombose. Body weight and age of 
the child were not significantly different when HAT patients 
and controls were compared-however, there was an apparent 
trend correlating these variables with the size of the recipient 
hepatic artery, although this was not statistically significant. 
Moreover, in pediatric liver transplantation it is not uncommon 
to observe a lack of correlation between the size of the patient 
and the diameter of the hepatic artery. This is due to the 
hemodynamic derangement related to the liver disease, which 
is the most important factor in determining the arterial supply 
to the organ. 
A higher incidence of HAT has been reported in association 
with the use of iliac arterial grafts and aortic conduits (1, 17). 
In the present series, the use of vascular allografts has been 
confirmed to be a risk factor in the development of early 
thrombosis, at least in children. Of 7 (70%) of the arterial 
reconstructions that required an iliac allograft or aortic conduit, 
5 (70%) eventually thrombosed. Vascular grafts create turbu-
lence, and this may be a factor in causing thrombosis. All grafts, 
in fact, were placed in the infrarenal position, with a possible 
turbulent inflow due to the position and length of the conduit. 
The supraceliac aorta may be a more favorable inflow location, 
although this technique deserves thorough examination. Rejec-
tion mechanisms directed at the vascular endothelial cell may 
offer another possible explanation (18). 
The third significant surgical risk factor for thrombosis was 
the number of times the anastomosis had to be redone. Ob-
viously the more times the anastomosis is redone, the greater 
the risk of intimal dissection, kinking, and excessive shortening 
of the .. vessel. Assessment of the adequacy of anastomosis by 
palpation of a thrill is quite subjective. Use of electromagnetic 
flow probes to accurately determine blood flow and assess the 
risk of HAT has recently been reported (19). Although deter-
mination of flow using this modality in small vessels is also 
subject to speculation, our preliminary data in pediatric recip-
ients suggest that a flow rate <60 ml/min significantly increases 
the incidence of HAT (Yanaga, et aI., manuscript submitted). 
The three surgical variables that were related significantly 
to the occurrence of HAT are also interrelated. A multivariate 
analysis failed to identify anyone of them as an independent 
risk factor for thrombosis unless not considering the heparin 
treatment. 
The level of the anastomosis did not correlate with the 
incidence of thrombosis. However, this finding may be related 
to the influence of other factors. For example, the level of the 
anastomosis is often determined by vessel size in order to have 
the best match between donor and recipient arteries. Also, 
sometimes the level of reconstruction is determined by whether 
an anastomosis has required revision; both the size of the vessel 
and the number of times that the anastomosis has required 
revision are known risk factors, therefore the influence of the 
level of the anastomosis on the occurrence ofthrombosis cannot 
definitively be ruled out. The splenic artery ligation performed 
in two patients of this series was not burdened with complica-
tions-however, because of the small number of cases the 
prophylactic ligation of splenic artery requires further evalua-
tion. 
The perioperative and intraoperative coagulation profiles 
were not significantly different between the two groups studied 
(Table 3, part I). Blood loss and the quantity of transfusions 
have previously been correlated with survival in children after 
OLTx (20). In our study the quality of transfusion, instead of 
quantity, has resulted in a significant difference. The incidence 
of HAT was significantly higher in children who received 
intraoperative transfusion of FFP compared with children who 
did not receive any FFP at all. There is no documentation that 
FFP has a beneficial effect when used as a part of transfusion 
management of patients with massive hemorrhage; in acute 
blood loss, alternative therapies are equally satisfactory and 
considerably safer (21). The only indication for FFP adminis-
tration in cases of massive blood transfusion is when factors V 
and VIII are less than 25% of normal, as documented by 
laboratory measurement (22). The intraoperative use of FFP 
in pediatric liver recipients should be curtailed and used only 
when gross deficiency of coagulation factors has been demon-
strated by an assay. 
The use of postoperative anticoagulation correlated signifi-
cantly (P<.Ol) with patency of the hepatic artery after liver 
transplantation. This event is not surprising, since antithrom-
botic therapy is an essential tool in intensive care and preven-
tive medicine (23, 25). Dextran-40 and heparin appeared to be 
particularly effective in preventing hepatic artery thrombosis 
(Table 3, part Il). The risk (odds ratio) of developing HAT in 
patients who did not receive anticoagulant therapy was almost 
8 and 5 times greater than in patients who received heparin 
and dextran, respectively (Fig. 2). After a multivariate analysis, 
anticoagulation therapy surfaced as the only independent vari-
able influencing hepatic artery thrombosis. 
However, caution must be exercised in the interpretation of 
these results. The anticoagulation therapy, in fact, was not 
given in a controlled fashion because of the preliminary nature 
of this study. Although our results could be biased by including 
patients thought to be at high risk of thrombosis in the study, 
the postoperative anticoagulative therapy appears to be a sta-
tistically independent factor in preventing HAT. There are no 
other reports in the literature regarding the use of anticoagu-
lants in pediatric liver recipients to prevent HAT. If corrobo-
rated by other controlled prospective studies, routine prophy-
lactic administration of anticoagulant could be advocated, at 
least in the high-risk patients. 
Dextran has to be started intraoperatively to have the best 
effect (23). At the dosage used, allergic reactions and renal 
failure were not encountered. Similarly heparin was tolerated 
well. In a few patients with bleeding, temporary reduction of 
the dosage was effective in controlling the bleeding without 
further treatment. 
Because of the small number of cases, the full importance of 
either aspirin or persantine cannot be completely assessed in 
this study, even if their role in maintaining an appropriate 
long-term coagulative state seems to be important. 
It should be remembered that any severe coagulopathy due 
to early posttransplant liver failure has been excluded from the 
present study. These patients, in fact, might be expected to 
have a higher incidence of thrombosis because of poor perfusion 
of the liver and subsequent edema that compounds the problem 
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with poor hepatic artery flow. 
Other factors associated with HAT might include variables 
specific to the new liver itself, such as ischemia/reperfusion 
damage with endothelial swelling and different grades of rejec-
tion. Indirect proof of the importance of the former mechanism 
is evident from our current experience with the use of the new 
University of Wisconsin lactobionate liver preservation solu-
tion (26). 
The incidence of HAT after initiation of use of the Jacto-
bionate solution at the University of Pittsburgh (both adult 
and pediatric) appears considerably decreased compared with 
the period when Euro-Collins solution was being used (27). 
Better endothelial and parenchymal cell preservation undoubt-
edly has a strong influence on the maintenance of the micro-
vascular circulation, (26, 28) and therefore on the whole arterial 
and venous patency distal to the anastomosis. 
In summary, this is the first detailed and analytical retro-
spective report on hepatic artery thrombosis after liver trans-
plantation in pediatric patients. The study has described a large 
number of variables that may influence the development of this 
complication-but, most important, has identified a group of 
factors that correlate statistically with the thrombotic event. 
The importance of an anticoagulation protocol following liver 
transplantation in high-risk patients is readily apparent. The 
results of this study should serve as a guideline for future 
prospective studies, and for the development of medicosurgical 
therapeutic protocols to overcome this dramatic complication. 
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